Cabaletta Bio (CABA) Times Interest Earned (2024 - 2026)
Cabaletta Bio (CABA) posted quarterly Times Interest Earned of -$5.9 for Q4 2025, up 84.39% year-over-year from -$3.2 in Q4 2024, and down 180.49% quarter-over-quarter from -$2.1 in Q3 2025.
Analysis
Cabaletta Bio (CABA) Times Interest Earned (2024 - 2026) Analysis & Trends
Cabaletta Bio's Times Interest Earned history runs 8 years deep, the most recent figure standing at -$5.9 for Q4 2025.
- In Q4 2025, Times Interest Earned rose 84.39% year-over-year to -$5.9; the TTM figure through Dec 2025 stood at -$18.48 (up 69.06% YoY), while the FY2025 annual figure was -$1.09, up 3.45% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$5.9, down from -$2.1 in the prior quarter.
- The five-year high for Times Interest Earned was $13.54 in Q4 2023, with the low at -$5869.5 in Q4 2021.
- The 5-year median for Times Interest Earned is -$1.62 (2022), against an average of -$296.89.
- The sharpest annual moves came in 2021 and 2023: Times Interest Earned sank 1025513.34% in 2021, then jumped 341.76% in 2023.
- Cabaletta Bio's Times Interest Earned stood at -$5869.5 in 2021, then soared by 99.9% to -$5.6 in 2022, then surged by 341.76% to $13.54 in 2023, then slumped by 379.03% to -$37.79 in 2024, then surged by 84.39% to -$5.9 in 2025.
- Business Quant data shows CABA's Times Interest Earned at -$5.9 in Q4 2025, -$2.1 in Q3 2025, and -$10.05 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Cabaletta Bio | 522.26 Mn | 522.26 Mn | - | -100.62 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -100.62 |
| Dec 31, 2025 | -76.78 |
| Sep 30, 2025 | -79.77 |
| Jun 30, 2025 | -80.40 |
| Mar 31, 2025 | -126.31 |
| Dec 31, 2024 | -45.17 |